Internal Medicine · Los Angeles, CA
NPI
1851609218
Since 2010
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
1520 San Pablo St, Suite 1000
Los Angeles, CA, 90033
Phone (323) 442-5100
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,752
24 services
Medicare patients, 2024
13
Average age 61
Drug cost, 2024
$448K
2,203 prescriptions
Company payments, 2025
$34.06
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Pavan R Yadav prescribed most often to Medicare patients was Levothyroxine Sodium, with 200 prescriptions and refills. In total Pavan R Yadav wrote 2,203 Medicare prescriptions that cost $448K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 200 | 654 | 72 | $5,189 |
| Insulin Glargine-Yfgn Generic | 193 | 435 | 68 | $28K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 189 | 289 | 62 | $4,019 |
| Methimazole Generic | 165 | 518 | 56 | $3,445 |
| Metformin Hcl Er Metformin Hcl | 122 | 352 | 46 | $896 |
| Humalog Kwikpen U-100 Insulin Lispro | 115 | 275 | 48 | $40K |
| Ozempic Semaglutide | 96 | 98 | 14 | $72K |
| Humalog Insulin Lispro | 72 | 162 | 27 | $16K |
| Cinacalcet Hcl Generic | 65 | 117 | 16 | $1,644 |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 65 | 164 | 22 | $24K |
| Glipizide Generic | 56 | 165 | 21 | $563 |
| Hydrocortisone Generic | 54 | 169 | 18 | $2,854 |
| Jardiance Empagliflozin | 53 | 175 | 20 | $33K |
| Humulin N Kwikpen Insulin Nph Human Isophane | 44 | 106 | 16 | $9,964 |
| Humulin N Insulin Nph Human Isophane | 41 | 110 | 16 | $7,248 |
Brand drugs: 935 claims; generic drugs: 981 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pavan R Yadav $34.06 ($34.06 in general payments such as food, travel and fees) from 1 company. The largest payer was Dexcom, Inc. with $34.06.
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. DXCM | 1 | $34.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.